Thursday - December 26, 2024
GSK and Zhifei Revise and Extend Strategic Vaccine Collaboration in China
December 06, 2024
LONDON, England, Dec. 6 (TNSres) -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release on Dec. 5, 2024:

* * *

- Shingrix collaboration extended to 2034

- Expanded exclusive rights to explore collaboration with Zhifei on Arexvy

- Creates sustainable, long-term collaboration to bring innovative vaccines to more than 500 million people in China

* * *

GSK plc (LSE/NYSE: GSK) toda . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products